Myasthenia Gravis Treatment EU Market: Growth, Trends, Segmented by Treatment (Immunotherapy & Surgery), and Distribution Channel (Hospitals, Clinics, Others) And Forecasts (2019 - 2028)
- Published Date: 2022-12-26
- Report ID: 138272
- Pages: 200
-
Format:
Report Overview
The EU Myasthenia Gravis Treatment market was valued at $675M in 2019 and is projected to expand at a CAGR of XX% from 2019 to 2028
Myasthenia gravis (MG) is a chronic, progressive, and rare neuromuscular disorder that is characterized by weakness of the head, limb, spinal, eye, and respiratory muscles. In this autoimmune disorder, antibodies are produced against the acetylcholine receptor (AchR) that impedes the normal transmission of electrical signals from nerves to muscles
Recently, Alexion Pharmaceuticals Soliris (eculizumab) received approval by both the FDA and the European Commission for the treatment of adult patients with generalized myasthenia gravis who are anti-AchR antibody-positive
1. EU Myasthenia Gravis Treatment Market Overview...
A. Market Size
2. Market Growth Drivers.......................
A. Increasing geriatric population in the EU
B. Rise in government initiatives
3. EU Myasthenia Gravis Treatment Market Segmentation.....................................
A. By Treatment
I. Immunotherapies
II. Surgery
B. By End-User
I. Hospitals
II. Clinics
III. Others
4. EU Myasthenia Gravis Treatment Market Share...
A. Market Analysis, Insights and Forecast to 2028 by Revenue
5. Competitive Landscape......
A. Major Players
B. Company Market Position Analysis
6. Key Company Profiles......
A. Novartis AG company overview, Product & Services, Strategies & Financials
B. AbbVie Inc. company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline PLC company profile, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy changes and Reimbursement scenario
8. Potential Growth Opportunities.....
A. Advancements in drug development
9. Factors Driving Future Growth..
A. Key Industry Trends and Recent Developments in EU Myasthenia Gravis Treatment Market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
